National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Adult Brain Tumors Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 01/02/2009



Purpose of This PDQ Summary






General Information






Classification






Treatment Option Overview






Brain Stem Gliomas






Pineal Astrocytic Tumors






Pilocytic Astrocytomas






Diffuse Astrocytomas






Anaplastic Astrocytomas






Glioblastoma






Oligodendroglial Tumors






Mixed Gliomas






Ependymal Tumors






Embryonal Cell Tumors: Medulloblastoma






Pineal Parenchymal Tumors






Meningeal Tumors






Germ Cell Tumors






Tumors of the Sellar Region: Craniopharyngioma






Recurrent Brain Tumors






Metastatic Brain Tumors






Get More Information From NCI






Changes to This Summary (01/02/2009)






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Changes to This Summary (01/02/2009)

The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Classification

Added text about salvage radiation therapy that has been used in patients whose tumors were incompletely resected (cited Leenstra et al. as reference 32).

Treatment Option Overview

Added text to include epidermal growth factor receptor inhibitors and vascular endothelial growth factor inhibitors, and other antiangiogenesis agents to the novel biologic therapies under clinical evaluation (cited Fine as reference 12).

Added Ogawa et al. as reference 16.

Pilocytic Astrocytomas

Added Stüer et al. as reference 3.

Glioblastoma

Added text about patients with glioblastoma multiforme in a clinical trial who were randomly assigned to receive radiation therapy plus supportive care or supportive care only (cited Keime-Guibert et al. as reference 1 and level of evidence 1iiA).

Added Chamberlain et al. as reference 14.

Embryonal Cell Tumors: Medulloblastoma

Added Brandes et al. as reference 4.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov